Page last updated: 2024-08-26

aucubin and Parkinsonian Disorders

aucubin has been researched along with Parkinsonian Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, X; Cui, C; Jia, XB; Shen, YQ; Sun, MF; Xu, YD; Xu, ZH; Yang, XS; Zhang, PH; Zhou, ZL; Zhu, YL	1

Other Studies

1 other study(ies) available for aucubin and Parkinsonian Disorders

Article	Year
Aucubin alleviates glial cell activation and preserves dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian mice. Neuroreport, 2018, 09-05, Volume: 29, Issue:13 Topics: Animals; Astrocytes; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Iridoid Glucosides; Male; Mice, Inbred C57BL; Microglia; Motor Activity; Neuroprotective Agents; Parkinson Disease; Parkinsonian Disorders; Substantia Nigra; Tyrosine 3-Monooxygenase	2018

Article

Year

Aucubin alleviates glial cell activation and preserves dopaminergic neurons in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian mice.

Neuroreport, 2018, 09-05, Volume: 29, Issue:13

Topics: Animals; Astrocytes; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Iridoid Glucosides; Male; Mice, Inbred C57BL; Microglia; Motor Activity; Neuroprotective Agents; Parkinson Disease; Parkinsonian Disorders; Substantia Nigra; Tyrosine 3-Monooxygenase

2018